Kwality Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE552U01010
  • NSEID:
  • BSEID: 539997
INR
1,450.00
-13.5 (-0.92%)
BSENSE

Mar 25

BSE+NSE Vol: 26.9 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002639,
    "name": "Kwality Pharma",
    "stock_name": "Kwality Pharma",
    "full_name": "Kwality Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/kwality-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,450.00",
    "chg": -13.5,
    "chgp": "-0.92%",
    "dir": -1,
    "prev_price": "1,463.50",
    "mcapval": "1,530.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539997,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE552U01010",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "26.9 k",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kwality-pharma-1002639-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "RP",
      "url": "https://www.marketsmojo.com/mojopro/strategy/3",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kwality-pharma-1002639-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Kwality Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-ltd-is-rated-buy-3892107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KwalityPharmace_mojoScore_3892107.png",
        "date": "2026-03-15 10:10:23",
        "description": "Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Kwality Pharmaceuticals Gains 8.99%: 3 Key Factors Driving the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-gains-899-3-key-factors-driving-the-rally-3890966",
        "imagepath": "",
        "date": "2026-03-14 12:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Mar 09:</strong> Stock opens week at Rs.1,492.95 with 2.91% gain despite Sensex decline</p>\n                    <p><strong>Mar 11:</strong> New 52-week high at Rs.1,674 amid strong sector outperformance</p>\n                    <p><strong>Mar 12:</strong> All-time high reached at Rs.1,740 despite broader market weakness</p>\n                    <p><strong>Mar 13:</strong> Week closes at Rs.1,581.10, up 8.99% for the week versus Sensex down 4.87%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,450.75</div></div>\n                    <div class=\"stat-item\">..."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Hits All-Time High at Rs.1740",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-all-time-high-at-rs1740-3887834",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KwalityPharmace_priceRelatedfactors_3887834.png",
        "date": "2026-03-12 20:35:01",
        "description": "Kwality Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.1740 on 12 Mar 2026, underscoring a remarkable period of sustained growth and robust financial performance."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Hits New 52-Week High at Rs.1740",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1740-3887029",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KwalityPharmace_priceRelatedfactors_3887029.png",
        "date": "2026-03-12 11:21:42",
        "description": "Kwality Pharmaceuticals Ltd has surged to a fresh 52-week and all-time high of Rs.1740, marking a significant milestone in its market performance. This achievement underscores the stock’s robust momentum amid a challenging broader market environment."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Hits New 52-Week High at Rs.1674",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1674-3885072",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KwalityPharmace_priceRelatedfactors_3885072.png",
        "date": "2026-03-11 10:58:10",
        "description": "Kwality Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week and all-time high of Rs.1674 today, marking a notable surge in its stock price amid a challenging broader market environment."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-ltd-is-rated-buy-3868927",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KwalityPharmace_mojoScore_3868927.png",
        "date": "2026-03-04 10:10:34",
        "description": "Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Hits All-Time High Amid Robust Financial Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-all-time-high-amid-robust-financial-performance-3860392",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KwalityPharmace_priceRelatedfactors_3860392.png",
        "date": "2026-02-27 13:17:10",
        "description": "Kwality Pharmaceuticals Ltd has reached a significant milestone by hitting its all-time high, reflecting a sustained period of strong performance and market confidence. The stock’s recent surge underscores the company’s solid fundamentals and consistent growth trajectory within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd’s Volatile Week: -0.45% Price Change Amidst New Highs and Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltds-volatile-week--045-price-change-amidst-new-highs-and-market-fluctuations-3849554",
        "imagepath": "",
        "date": "2026-02-21 13:00:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Feb:</strong> New 52-week and all-time high reached near Rs.1,572</p>\n                    <p><strong>18 Feb:</strong> Stock hits fresh 52-week and all-time high at Rs.1,599</p>\n                    <p><strong>18 Feb:</strong> Notable intraday surge of 10.02%</p>\n                    <p><strong>20 Feb:</strong> Week closes lower at Rs.1,424.70 (-1.99% on day)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,431.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,424.70</div><div ..."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-ltd-is-rated-buy-3849284",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KwalityPharmace_mojoScore_3849284.png",
        "date": "2026-02-21 10:10:31",
        "description": "Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 21 February 2026, providing investors with the most up-to-date insight into the stock’s performance and outlook."
      }
    ],
    "total": 262,
    "sid": "1002639",
    "stock_news_url": "https://www.marketsmojo.com/news/kwality-pharmaceuticals-1002639"
  },
  "announcements": [
    {
      "caption": "Update On Bioequivalence (BE) Program - Successful Completion Of Phase 1 By Kwality Pharmaceuticals Ltd.",
      "datetime": "10-Mar-2026",
      "details": "Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Updation on Bioequivalence (BE) Program- Successful Completion of Phase 1 by Kwality Pharmaceuticals Limited",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "05-Mar-2026",
      "details": "Intimation of Schedule of Analysts/ Institutional Investors Meeting to be held on March 10 2026 at 4:00 P.M.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "05-Mar-2026",
      "details": "Intimation of Schedule of Analysts/Institutional Investors Meeting to be held on March 12 2026 through an in-person Site Visit.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kwality Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 05 Jan 17",
          "dt": "2017-01-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Kwality Pharmaceuticals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Oct 17",
          "dt": "2017-10-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Kwality Pharmaceuticals Gains 8.99%: 3 Key Factors Driving the Rally

2026-03-14 12:00:05

Key Events This Week

Mar 09: Stock opens week at Rs.1,492.95 with 2.91% gain despite Sensex decline

Mar 11: New 52-week high at Rs.1,674 amid strong sector outperformance

Mar 12: All-time high reached at Rs.1,740 despite broader market weakness

Mar 13: Week closes at Rs.1,581.10, up 8.99% for the week versus Sensex down 4.87%

stock-recommendationAnnouncement

Update On Bioequivalence (BE) Program - Successful Completion Of Phase 1 By Kwality Pharmaceuticals Ltd.

10-Mar-2026 | Source : BSE

Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Updation on Bioequivalence (BE) Program- Successful Completion of Phase 1 by Kwality Pharmaceuticals Limited

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

05-Mar-2026 | Source : BSE

Intimation of Schedule of Analysts/ Institutional Investors Meeting to be held on March 10 2026 at 4:00 P.M.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

05-Mar-2026 | Source : BSE

Intimation of Schedule of Analysts/Institutional Investors Meeting to be held on March 12 2026 through an in-person Site Visit.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Kwality Pharmaceuticals Ltd has declared 6% dividend, ex-date: 05 Jan 17

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Kwality Pharmaceuticals Ltd has announced 1:1 bonus issue, ex-date: 11 Oct 17

stock-summary
RIGHTS

No Rights history available